Probiosis-5

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

Saccharomyces cerevisiae (Boulardii), Quantity: 5 billion CFU; Lactobacillus gasseri, Quantity: 2 billion CFU; Lactobacillus reuteri, Quantity: 3 billion CFU; Bifidobacterium breve, Quantity: 5 billion CFU; Lactobacillus rhamnosus, Quantity: 5 billion CFU

Available from:

Spectrumceuticals Pty Ltd

INN (International Name):

Bifidobacterium breve,Lactobacillus gasseri,Lactobacillus reuteri,Lactobacillus rhamnosus,Saccharomyces cerevisiae (Boulardii)

Pharmaceutical form:

Capsule, hard

Composition:

Excipient Ingredients: colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; hypromellose; purified water

Administration route:

Oral

Therapeutic indications:

Maintain/support general health and wellbeing ; Maintain/support intestinal health ; Maintain/support intestinal good/beneficial/friendly flora ; Maintain/support small intestine good/beneficial/friendly flora ; Maintain/support gastrointestinal system health ; Maintain/support gastrointestinal mucosal membrane health ; Maintain/support immune system health ; Maintain/support healthy immune system function ; Maintain/support healthy gastrointestinal immune function

Product summary:

Visual Identification: ;

Authorization status:

Licence status A

Authorization date:

2017-09-13